Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
544.8 USD | +0.60% | -2.35% | +2.64% |
Apr. 17 | TD Cowen Raises Price Target on Thermo Fisher Scientific to $644 From $612 | MT |
Apr. 17 | HSBC Adjusts Thermo Fisher Scientific Price Target to $660 From $630 | MT |
Evolution of the average Target Price on Thermo Fisher Scientific
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Thermo Fisher Scientific
TD Cowen | |
HSBC | |
RBC Capital Markets | |
Raymond James | |
UBS | |
Deutsche Bank Securities | |
Stifel Nicolaus | |
Goldman Sachs | |
Evercore ISI | |
Jefferies & Co. | |
Barclays | |
Baird | |
BofA Securities | |
Bernstein | |
Citigroup | |
Morgan Stanley | |
KeyBanc Capital Markets | |
Nephron Research | |
Atlantic Equities | |
Morningstar | |
JPMorgan Chase | |
Credit Suisse | |
Cowen | |
SVB Securities LLC | |
Wells Fargo Securities | |
SVB Leerink | |
BTIG | |
Argus | |
Benchmark Capital | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- TMO Stock
- Consensus Thermo Fisher Scientific